Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Holger Amthauer

Showing results (171-180 of 197) with videos related to

Pageof 20
Sort By:
European Radiology Experimental|January 28, 2024
Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and <sup>99m</sup>Tc-mebrofenin hepatobiliary scintigraphyMatthias P Fabritius, Benjamin Garlipp, Osman Öcal, et al.
International Journal of Cancer|February 4, 2020
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancerSebastian Zschaeck, Yimin Li, Rebecca Bütof, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 2, 2021
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert PerspectivesFrederik A Verburg, Holger Amthauer, Ina Binse, et al.
Acta Oncologica (Stockholm, Sweden)|May 6, 2020
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trialTim A Labeur, Quincy Hofsink, R Bart Takkenberg, et al.
Plos One|July 31, 2020
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patientsSebastian Zschaeck, Yimin Li, Qin Lin, et al.
Journal of Hepatology|August 18, 2019
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinomaJens Ricke, Heinz Josef Klümpen, Holger Amthauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2010
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parametersTimm Denecke, Patrick Hundsdörfer, Daniel Misch, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
Scientific Reports|October 20, 2020
A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiationYimin Li, Marcus Beck, Tom Päßler, et al.
Diagnostics (Basel, Switzerland)|December 16, 2020
Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume DefinitionJosefine Graef, Carolin Senger, Christoph Wetz, et al.
Pageof 20

Showing results (171-180 of 197) with videos related to

Sort By:
Pageof 20
European Radiology Experimental|January 28, 2024
Assessing regional hepatic function changes after hypertrophy induction by radioembolisation: comparison of gadoxetic acid-enhanced MRI and <sup>99m</sup>Tc-mebrofenin hepatobiliary scintigraphyMatthias P Fabritius, Benjamin Garlipp, Osman Öcal, et al.
International Journal of Cancer|February 4, 2020
Combined tumor plus nontumor interim FDG-PET parameters are prognostic for response to chemoradiation in squamous cell esophageal cancerSebastian Zschaeck, Yimin Li, Rebecca Bütof, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 2, 2021
Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert PerspectivesFrederik A Verburg, Holger Amthauer, Ina Binse, et al.
Acta Oncologica (Stockholm, Sweden)|May 6, 2020
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trialTim A Labeur, Quincy Hofsink, R Bart Takkenberg, et al.
Plos One|July 31, 2020
Prognostic value of baseline [18F]-fluorodeoxyglucose positron emission tomography parameters MTV, TLG and asphericity in an international multicenter cohort of nasopharyngeal carcinoma patientsSebastian Zschaeck, Yimin Li, Qin Lin, et al.
Journal of Hepatology|August 18, 2019
Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinomaJens Ricke, Heinz Josef Klümpen, Holger Amthauer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 28, 2010
Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parametersTimm Denecke, Patrick Hundsdörfer, Daniel Misch, et al.
The Oncologist|April 8, 2026
Comprehensive molecular analyses for diagnosis and treatment guidance in an adult neuroblastoma patientDamian T Rieke, Stefan Schwartz, Sebastian Ochsenreither, et al.
Scientific Reports|October 20, 2020
A FDG-PET radiomics signature detects esophageal squamous cell carcinoma patients who do not benefit from chemoradiationYimin Li, Marcus Beck, Tom Päßler, et al.
Diagnostics (Basel, Switzerland)|December 16, 2020
Shortened Tracer Uptake Time in GA-68-DOTATOC-PET of Meningiomas Does Not Impair Diagnostic Accuracy and PET Volume DefinitionJosefine Graef, Carolin Senger, Christoph Wetz, et al.
Pageof 20